AURA
Aura Biosciences Inc
NASDAQ: AURA · HEALTHCARE · BIOTECHNOLOGY
$7.05
+4.75% today
Updated 2026-04-30
Market cap
$432.06M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.76
Dividend yield
—
52W range
$4 – $8
Volume
0.3M
Aura Biosciences Inc (AURA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-20.67M | $-24.32M | $-32.41M | $-54.60M | $-63.85M | $-79.81M | $-84.74M |
| Capital expenditures | $2.22M | $771000.00 | $2.13M | $1.09M | $709000.00 | $1.25M | $447000.00 |
| Depreciation | $509000.00 | $831000.00 | $831000.00 | $1.18M | $1.29M | $1.22M | — |
| Stock-based comp | $507000.00 | $736000.00 | $2.31M | $6.41M | $8.77M | $11.72M | $14.32M |
| Free cash flow | $-22.89M | $-25.09M | $-34.53M | $-55.70M | $-64.56M | $-81.06M | $-85.19M |
| Investing cash flow | $-2.22M | $-771000.00 | $-2.13M | $-67.87M | $-113.96M | $68.82M | — |
| Financing cash flow | $39.73M | $10.04M | $166.26M | $95.63M | $97.29M | $1.59M | — |
| Dividends paid | $39.76M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $131.72M | $-26.84M | — | — | — |